These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 25090924)

  • 1. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast reduces seizures in pentylenetetrazol-kindled mice.
    Fleck J; Temp FR; Marafiga JR; Jesse AC; Milanesi LH; Rambo LM; Mello CF
    Braz J Med Biol Res; 2016; 49(4):e5031. PubMed ID: 26909785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast potentiates the anticonvulsant effect of phenobarbital in mice: an isobolographic analysis.
    Fleck J; Marafiga JR; Jesse AC; Ribeiro LR; Rambo LM; Mello CF
    Pharmacol Res; 2015 Apr; 94():34-41. PubMed ID: 25684626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of leukotriene D4 attenuates the development of seizures in mice.
    Rehni AK; Singh TG
    Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):97-106. PubMed ID: 21641195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukotriene D4 activates BV2 microglia in vitro].
    Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
    Funck VR; de Oliveira CV; Pereira LM; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Guerra GP; Furian AF; Oliveira MS; Mallmann CA; de Mello CF; Oliveira MS
    Epilepsia; 2011 Nov; 52(11):2094-104. PubMed ID: 21906051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
    Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
    Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
    Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
    Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
    Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
    Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast inhibits pentylenetetrazol-induced seizures in rats.
    Cevik B; Solmaz V; Aksoy D; Erbas O
    Med Sci Monit; 2015 Mar; 21():869-74. PubMed ID: 25803241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia.
    Gurses C; Ekizoglu O; Orhan N; Ustek D; Arican N; Ahishali B; Elmas I; Kucuk M; Bilgic B; Kemikler G; Kalayci R; Karadeniz A; Kaya M
    Brain Res; 2009 Jul; 1281():71-83. PubMed ID: 19464270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
    Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
    J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
    Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
    Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
    Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
    Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
    Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
    J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.